Flexiquit+: Web Program to Promote Smoking Cessation in Sexual and Gender Minority Young Adult Smokers
EQQUAL
A Scalable E-Health Smoking Cessation Intervention for Sexual and Gender Minority Young Adults
4 other identifiers
interventional
25
1 country
1
Brief Summary
This phase I trial studies how well Flexiquit+ helps young adult smokers who identify as a sexual and/or gender minority to quit or cut down on smoking. Flexiquit+ is an avatar-led, web-based intervention that can help smokers quit or cut back on how much they smoke cigarettes and/or vape, reducing their chances of developing tobacco-related health conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started May 2020
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2019
CompletedFirst Posted
Study publicly available on registry
December 11, 2019
CompletedStudy Start
First participant enrolled
May 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedOctober 5, 2020
October 1, 2020
4 months
December 9, 2019
October 2, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Treatment utilization
Will be determined by the server-recorded number of logins and the number of sessions completed. Frequencies (for categorical variables) or means and standard deviations (for continuous variables) will be reported for treatment utilization and satisfaction. Tables with N (%) or mean (standard deviation) by treatment arm will be provided.
Enrollment up to 2 months
Treatment satisfaction: survey
Will be determined using 12 items on the 2-month outcome survey. Frequencies (for categorical variables) or means and standard deviations (for continuous variables) will be reported for treatment utilization and satisfaction. Categorical ratings for treatment satisfaction questions will be dichotomized as "somewhat", "mostly", or "very" useful versus (vs.) lower ratings. Tables with N (%) or mean (standard deviation) by treatment arm will be provided.
Enrollment up to 2 months
Secondary Outcomes (2)
Smoking cessation rate
At 2 months post-enrollment
Change in motivation to quit smoking
From baseline to 2-month follow-up
Study Arms (1)
Prevention (Flexiquit+, text message, handout)
EXPERIMENTALIndividuals will be recruited to use the Flexiquit+ program consisting of 6 sessions, each lasting approximately 25 minutes. Participants will also receive text messages providing motivational messages and review information discussed in the program. At the end of the intervention, participants will receive an email with all of the session handouts.
Interventions
Use the Flexiquit+ program
Receive text messages
Ancillary studies
Eligibility Criteria
You may qualify if:
- Participants must self-identify as a sexual and/or gender minority (i.e., a sexual orientation other than straight and/or gender that doesn't match sex assigned at birth)
- Participants must currently reside in the United States and anticipate remaining in the United States for the duration of the study (2 months)
- Participants must self-report smoking at least 1 cigarette per day in the 30 days prior to screening
- Participants must self-report having at least weekly internet access for the next two months
- Participants must self-report being willing and able to stream video online for this study
- Participants must self-report current use of a personal email account
- Participants must self-report current use of text messaging
- Participants must self-report that they are interested in participating in the study for themselves (versus \[vs\] someone else)
- Participants must self-report that they are not currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program
- Participants must self-report that they have not participated in one of our prior smoking cessation studies, including the user-centered research conducted in the development of Flexiquit+
- Participants must self-report that they are comfortable reading, writing, and speaking English
- Participants must self-report that they understand and agree to the conditions of compensation
- Participants must self-report that they are not currently incarcerated in a prison
- Participants must be willing to use the Flexiquit+ program, complete the study assessments, and sign an online consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fred Hutchinson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
- The Safeway Foundationcollaborator
Study Sites (1)
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jaimee Heffner
Fred Hutch/University of Washington Cancer Consortium
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 9, 2019
First Posted
December 11, 2019
Study Start
May 18, 2020
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
October 5, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share